Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid Regression: Immunohistochemistry, Histopathology and Imaging Study

NCT04326959 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.

NCT NCT04326959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04326959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid Regression: Immunohistochemistry, Histopathology and Imaging Study
Lead sponsor
PT. Prodia Stem Cell Indonesia
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 1, 2020
Completion date
December 1, 2020
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

keloid